Contracts Finder · Tender

GB-Middlesbrough: BIOS ICP-OES

A public procurement published by Teesside University via Contracts Finder.

Contracts FinderTender
Award value
£500k
Tender value
0
Suppliers
0
Awards
1
Notices
Tender
Stage

Overview

Teesside University as part of its ambitious campus masterplan is building an innovative new home for its Medical and Life Sciences offer. The BIOS Building is scheduled to be open for September 2023 and will house state of the art facilities and equipment. The School of Health & Life Sciences is looking to Purchase 1x ICP-OES to be used to support science work within its new BIOS facility. Additional information: The contracting authority considers that this contract may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement.

Key details

Source
Contracts Finder
Lifecycle stage
Tender
Status
active
CPV classification
38433000 — Spectrometers
Currency
GBP
Total award value
Tender value
£500,000
First published
23 Jan 2023
Last updated
23 Jan 2023
View the original notice

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Tender noticeGB-Middlesbrough: BIOS ICP-OES

Frameworks & programmes

More from Teesside University

FAQs about this procurement

Who is the buyer for "GB-Middlesbrough: BIOS ICP-OES"?

GB-Middlesbrough: BIOS ICP-OES is a UK public-sector procurement published by Teesside University via Contracts Finder.

Has "GB-Middlesbrough: BIOS ICP-OES" been awarded?

No award has been recorded yet. The current lifecycle stage is "Tender".

What is "GB-Middlesbrough: BIOS ICP-OES" worth?

The reported tender value is £500,000.

When was "GB-Middlesbrough: BIOS ICP-OES" published?

It was first published on 23 Jan 2023 and last updated on 23 Jan 2023, across 1 notice.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable